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Objectives: The aim of this study was to determine the influence of the degree of porosity on the release of growth factors 
(PDGF AA, PDGF BB, bFGF) by healing PTFE grafts. 
Design and setting: Laboratory animal study. 
Materials: 1 cm long segments of non-reinforced PTFE grafts (30 microns fibril length, 2 mm internal diameter, 0.39 mm 
thick) were placed as an abdominal aortic interposition in Lewis rats. Fifteen grafts served as control (Group A; porous 
grafts); in eight rats (Group B; non porous grafts) the PTFE graft was completely wrapped by a non-porous plastic 
envelope. Animals were killed 4 weeks after surgery. 
Outcome measures: The release of PDGF AA, PDGF BB, and bFGF was assessed by Enzyme Linked Immunosorbent 
Assay (ELISA). 
Results: The release of PDGF AA, PDGF BB and bFGF was statistically higher in porous grafts. The only histological 
difference between the two groups was that porous PTFE grafts were invaded by many tufts of capillaries from the 
surrounding tissue, whereas this phenomenon was absent in non porous PTFE grafts. 
Conclusions: The degree of porosity influences the release of growth factors by healing PTFE grafts. This fact may have 
implication in the endotheIisation f PTFE grafts and in myointimal hyperplasia formation as well. 
Introduction 
,Synthetic vascular grafts implanted in humans lack a 
confluent endothelial lining even after several years. ~'2 
The endothelium over a synthetic graft derives mainly 
from migration of endothelial cells from the adjacent 
artery as a continuous layer across the anastomosis 
and from transinterstitial c pillary ingrowth. 3-5 Trans- 
mural capillary ingrowth is very limited in humans 
and, theoretically, endothelisation f synthetic grafts 
in humans could be obtained by increasing the rate of 
transmural capillary migration. 6 Many attempts have 
been made to increase the porosity of synthetic grafts 
and possibly transmural capillary ingrowth to allow 
early endothelisation. 7's 
Platelet Derived Growth Factor (PDGF) and basic 
Fibroblastic Growth Factor (bFGF) are two of the best 
characterised mitogens for endothelial cells and 
smooth muscle cells. 9-11 PDGF consists of glycopro- 
teins that exist as dimer of two distinct but related 
chains termed PDGF -A and PDGF-B. PDGF is a major 
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mitogen for connective tissue cells in culture and has 
been shown to be chemotactic for smooth muscle cells. 
bFGF is a member of the heparin binding mitogens, 
characterised by their affinity for heparin and their 
ability to stimulate both endothelial and smooth 
muscle cells proliferation. Theoretically; PDGF and 
bFGF production by cells invading the graft could 
promote on one hand further transmural capillary 
ingrowth and neointima formation, and on the other, 
myointimal hyperplasia formation. 
The aim of this study was to analyse the release of 
bFGF and PDGF by porous and non-porous PTFE 
grafts. 
Material and Methods 
Experimental design 
In 23 male inbred Lewis rats (average weight 250 g) a 
1 cm long segment of non-reinforced PTFE graft (30 
microns fibril length; 2mm internal diameter; 0.39 mm 
thick WL Gore and Assoc Inc; Flagstaff, AZ, U.S.A.) 
was inserted in the arterial system, at the level of the 
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abdominal aorta. Fifteen animals served as control 
group (Group A; porous grafts); in eight animals the 
graft was wrapped by a non-porous plastic envelop 
(Parafilm M American National Can Greenwich, CT, 
U.S.A.) (Group B; non porous grafts) to avoid trans- 
mural capillary ingrowth. Four weeks after surgery 
the animals were sacrificed and the PTFE grafts 
removed and studied in an organ culture for assess- 
ment of mitogenic activity and release of PDGF AA, 
PDGF BB, and bFGF. 
Operative procedures 
The animals were anaesthetised with intramuscular 
Xylazine (3 mg/kg) and intramuscular ketamine (50 
mg/kg) supplemented by intraperitoneal ketamine 
for maintenance. Surgery was performed with the use 
of an operating microscope (Zeiss OPMI-7D). The 
abdomen was opened and the abdominal aorta identi- 
fied, and both proximal and distal control obtained. 
The PTFE graft was inserted with end-to-end anasto- 
moses using 10-0 monofilament nylon sutures (Ethi- 
con Inc). Four weeks after surgery, the animals were 
anaesthetised and the abdomen and chest opened. The 
aorta above and below the graft and the grafts were 
exposed and excised. 
antibiotics at pH 7.4. The tissue was incubated for 5 
days at 37°C in a 5% CO2 atmosphere. Aliquots of 
conditioned media were collected at 24, 72, and 120 h 
and centrifuged for 5 min at 15000 rpm and the 
supernatant stored at -80°C for assay of mitogenic 
activity and assay of PDGF AA, PDGF BB and bFGF 
release. 
Assay for mitogenic activity 
Swiss 3T3 cells were plated in 96 well plates (Falcon, 
Plastics) at a density of 4 × 104 cells/ml in 200 ~1 of 
DMEM supplemented with 0.1% Foetal Calf Serum 
(FCS). At 72 h conditioned serum free media from 
PTFE grafts and aortic segments were added to Swiss 
3T3 cells (20/zl). Positive controls received an equiva- 
lent volume of DMEM plus human recombinant bFGF 
(20 ng/ml) or human recombinant PDGF (50 ng/ml) 
(Genzyme Co, Boston, MA, U.S.A.); negative controls 
received only DMEM. After 2 days, tritiated thymi- 
dine (0.5 /z Ci per well plate) was added and the 
cultures were incubated for 18 h and collected on 
Skatron Filters (Skatron Instruments; Sterling, VA, 
U.S.A.) for radioactivity determination in a LKB 
scintillation counter. 
Histology 
For each group, grafts were perfusion fixed with an 
initial infusion of Hanks balanced salt solution, 
followed by 10% formaldehyde. Serial tranverse and 
longitudinal sections were performed. Three grafts in 
the porous PTFE group and two grafts in the non 
porous PTFE group were used for histology. 
Organ culture 
Twelve grafts in the porous PTFE group and six grafts 
in the non-porous PTFE group were used for this 
study. The PTFE grafts and aortic segments were 
opened longitudinally and rinsed thoroughly for 10 
min with Dulbecco Modified Eagle Medium (DMEM) 
supplemented with antibiotics (Gentamycin 200 
/zg/ml; Streptomycin 100 /zg/ml; Penicillin 100 IU/ 
ml). The specimens were plated in 48 well Costar 
tissue culture plates for organ culture. The tissue was 
incubated in 1 ml of DMEM supplemented with 
Analysis of reduction of mitogenic activity by anti-PDGF 
and anti-bFGF antibody 
Measurement of the Swiss 3T3 cells DNA synthesis - 
stimulating activity of the conditioned media from 
porous and non porous PTFE grafts was repeated in 
the presence of an excess of monospecific antibody to 
PDGF (Genzyme Co, Boston, MA, U.S.A.) and in the 
presence of an excess of monoclonal antibody to bFGF 
(produced in our laboratory). Tritiated thymidine was 
again added and the cultures were incubated for 18 h. 
After further processing the radioactivity was 
measured. 
Assay of PDGF AA, PDGF BB and bFGF in the 
conditioned media 
The presence of bFGF, PDGF AA and PDGF BB in the 
serum-free conditioned media from porous and non 
porous PTFE grafts, and aortic segments was deter- 
mined by an inhibition antibody-binding assay. A 
dilution of anti-bFGF monoclonal antibody that 
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showed 50% maximal reactivity against bFGF was 
incubated with various dilutions of conditioned media 
in 400 /xl tubes precoated with Phosphate Buffered 
Saline (PBS) gelatin 2%. After 20 h of incubation at 
4°C, Staphylococcus aureus Protein A was added, and 
the immunoaggregates were removed by centrifuga- 
tion. The residual antibody-binding activity in the 
supernatant was measured by ELISA, according to a 
method already described. 12 In brief, plastic wells 
were coated with bFGF (10 ng/well) for 8 h at 4°C. 
Plates were then washed twice with PBS and saturated 
with PBS-gelatin 1% for 2 h at 37°C. Washed wells 
were then filled with 50/xl per well of supernatant 
obtained after immunoprecipitation. After 2 h of 
incubation at 37°C the wells were washed with PBS 
gelatin 0.1%. Peroxidase labeled goat anti-mouse 
immunoglobulin a tibody was added. After 60 min of 
incubation at 37°C the plate was washed three times in 
PBS-gelatin 0.1% and once in distilled water. Finall3~ 
O-phenylenediamine dihydrochloride (0.4 mg/ml) 
(Sigma, St Louis, MO, U.S.A.) was added as substrate 
for the enzyme. Bound specific antibody was quantita- 
tively measured by optical density reading at 492 nm 
with a spectrophotometer (Beckman Instruments, In, 
Bea, CA, U.S.A.). The amount of bFGF in the con- 
ditioned media was determined by using known 
quantities of human recombinant bFGF. We used 
mouse anti-bFGF monoclonal antibody as positive 
control and antibody without specificity as negative 
control. Similar experiments were used to determine 
the presence and amount of PDGF AA and PDGF BB 
in the conditioned media. 
Statistical analysis 
Chi-square test, analysis of variance and Student's 
t-test were used where appropriate. Data were 
expressed as mean + S.D. Differences were considered 
significant at the 5% level. 
Results 
Histology 
At harvest, PTFE grafts showed some minor degree of 
myointimal hyperplasia at the anastomoses. The 
tissue surrounding the porous PTFE grafts penetrated 
the interstices of the graft although only rare tufts of 
ingrowth tissue penetrated to the lumen surface (Fig. 
1). This phenomenon was absent in on-porous PTFE 
grafts (Fig. 2). 
Mitogenic activity of the conditioned media 
Addition of serum-free conditioned media from 
porous PTFE grafts produced a mean increase of 
tritiated thymidine uptake of Swiss 3T3 cell cultures of 
six-fold as compared with conditioned media from 
non-porous PTFE grafts (Fig. 3). 
Reduction of mitogenic activity by anti-PDGF and 
anti-bFGF antibodies 
Addition of monospecific anti-PDGF antibody to the 
medium of 3T3 cell cultures exposed to conditioned 
medium from porous PTFE grafts decreased the 
uptake of tritiated thymidine by 20% (p < 0.05). This 
Fig. 1. Longitudinal section of a porous PTFE graft, 4 weeks after 
implantation. I vasion of the graft by surrounding tissue (L = Lu- 
men) (H.E. × 250). Reproduced here at 85%. 
Fig. 2. Longitudinal section of a non porous PTFE graft, 4 weeks 
after implantation. Absence of invasion of the graft by surrounding 
tissue (L = Lumen) (H.E. × 250). Reproduced here at 85%. 
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effect was negligible in non-porous PTFE grafts (Fig. 
4). 
Addition of monospecific anti-bFGF antibody to the 
medium of 3T3 cell cultures exposed to conditioned 
medium from porous PTFE grafts decreased the 
uptake of tritiated thymidine by 65% (p < 0.001). This 
effect was negligible in non-porous PTFE grafts (Fig. 
5). 
PDGF and bFGF assay by ELISA 
Table 1 shows the release of PDGF AA, PDGF BB, and 
bFGF by porous and non-porous PTFE grafts. The 
release of PDGF AA, PDGF BB and bFGF was 
statistically higher in porous PTFE grafts (p < 0.001). 
Table 2 shows the release of PDGF AA, PDGF BB and 
bFGF from the aorta above and below the grafts; 
again, the release of growth factors was statistically 
higher in the aorta adjacent to porous PTFE grafts 
(p < 0.001). 
Discussion 
Synthetic vascular grafts implanted in humans lack an 
endothelial monolayer even after several years which 
is in marked contrast to the findings in animal 
experiments. Sauvage et aL 7 found that endothelial 
lining in Dacron grafts implanted in pig and calves 
was derived primarily from transintersticial ingrowth; 
6 months after implantation, endothelial cells covered 
impervious Dacron grafts only 2.0 to 2.5 cm from the 
anastomosis, whereas porous Dacron grafts were 
completely healed. Interestingly, transmural capillary 
ingrowth of Dacron grafts is very limited in humans, 
and this is the most striking difference between the 
healing pattern of vascular grafts in humans and that 
in experimental animals. Synthetic grafts remain lined 
by a mixed fibrin and platelet thrombus for a long 
time after implantation. The degree of porosity has an 
important role in inducing transmural ca~pillary 
ingrowth, at least in baboons. Clowes et al.°have 
shown that high porosity PTFE grafts (60 microns 
mean internodal distance) are completely covered by 
endothelial cells within 2 weeks in baboons, and that 
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Table 1. Release of growth factors (ng/cm 2/72 h) 
PDGF AA PDGF BB bFGF 
Porous PTFE grafts (n = 12) 28+4* 66+7* 404+_22* 
Non-porous PTFE grafts (n = 6) 17+3 7+3 21+_6 
*p<0.01 
transmural capillary ingrowth is more evident in 
porous grafts than in less porous grafts. Zacharias et 
al. 13 found that transmural capillary ingrowth is more 
pronounced in PTFE than Dacron grafts. In the rat 
model we found many tufts of tissue invading PTFE 
grafts with 30 microns internodal distance, even if few 
reached the lumen. 14 We do not know if this process 
will stop or whether the graft will be completely 
healed later and we are investigating this problem. 
We found, however, that more porous PTFE grafts 
release ahigher quantity of growth factors. The source 
of these growth factors can only be speculative, 
because the organ culture used does not allow 
identification of the cells responsible for the produc- 
tion of growth factors. Theoretically, the source of this 
increased release of PDGF AA, PDGF BB and bFGF 
could be the tissue invading the graft as the degree of 
porosity was the only difference between the two 
types of grafts (Fig. 6). Golden et al. ~5 found that the 
neointima of PTFE grafts implanted in baboons 
expressed higher levels of PDGF A mRNA than the 
native aorta. Kaufman et aI. ~6 found increased PDGF 
production in the distal portion of PTFE grafts 
implanted in dogs, where intimal thickness was 
greater. 
The role of these growth factors hould be source of 
controversy. They are mitogens for endothelial and 
smooth muscle cells. On one hand they could promote 
the formation of a graft neoendothelium by causing 
endothelial cellular migration and proliferation; but 
on the other hand they could lead to myointimal 
hyperplasia formation through smooth muscle cells 
proliferation with a detrimental effect on graft 
patency. The results of our study underline the 
bFGF 
Table 2. Release of growth factors (ng/cm 2/72 h) 
PDGF AA PDGF BB bFGF 
Anastomotic aorta proximal to 
porous PTFE grafts (n = 12) 40+6* 68+9* 85+10" 
Anastomotic aorta distal to 
porous PTFE grafts (n = 12) 42+9* 65+8* 110+15" 
Anastomotic aorta proximal to 
non-porous PTFE grafts (n =6) 17+4 23_+5 21+3 
Anastomotic aorta distal to 
non-porous PTFE grafts (n =6) 16+3 22+5 25+5 
Thoracic aorta (n = 18) 6+2 7+_4 21_+8 
*p<0.01 
Fig. 6. Schematic drawing showing hypothesis that tissue invading 
the graft might be the source of increased release of growth factors 
in porous PTFE grafts. 
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importance of a proper evaluation of the degree of 
porosity of synthetic arterial grafts not only in terms of 
neoendothelisation, but also in terms of myointimal 
hyperplasia formation. Grafts of different porosity 
may elicit different degrees of myointimal hyperplasia 
formation. Theoretically, if grafts more porous allow 
transmural tissue migration, they could also produce 
more growth factors, leading to myointimal 
hyperplasia. 
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